Article Versions Notes

Skurikhin EG, Pershina O, Ermakova N, Pakhomova A, Widera D, Zhukova M, Pan E, Sandrikina L, Kogai L, Kushlinskii N, et al. Reprogrammed CD8⁺ T-Lymphocytes Isolated from Bone Marrow Have Anticancer Potential in Lung Cancer. Biomedicines. 2022; 10(6):1450. https://doi.org/10.3390/biomedicines10061450

Skurikhin, Evgenii G., Olga Pershina, Natalia Ermakova, Angelina Pakhomova, Darius Widera, Mariia Zhukova, Edgar Pan, Lubov Sandrikina, Lena Kogai, Nikolai Kushlinskii, and et al. 2022. "Reprogrammed CD8⁺ T-Lymphocytes Isolated from Bone Marrow Have Anticancer Potential in Lung Cancer" Biomedicines 10, no. 6: 1450. https://doi.org/10.3390/biomedicines10061450

Skurikhin, E. G., Pershina, O., Ermakova, N., Pakhomova, A., Widera, D., Zhukova, M., Pan, E., Sandrikina, L., Kogai, L., Kushlinskii, N., Morozov, S. G., Kubatiev, A., & Dygai, A. (2022). Reprogrammed CD8⁺ T-Lymphocytes Isolated from Bone Marrow Have Anticancer Potential in Lung Cancer. Biomedicines, 10(6), 1450. https://doi.org/10.3390/biomedicines10061450